17.4K
Downloads
65
Episodes
IPA’s What, Why & How podcast unravels the intricacies of pharmacy and healthcare law and regulation, from Congress to the Board of Pharmacy. Each month, IPA’s CEO, Kate Gainer, welcomes a special guest to explore WHAT changes occurred, WHY action was taken, and HOW these changes will impact pharmacy practice.
Episodes
Oct 28, 2022
Oct 28, 2022
15 min
Following the October 25 Iowa Board of Pharmacy meeting, IPA staff and Andrew Funk from the Board of Pharmacy discuss the role of the Board and programs offered, updated USP compounding standards, and delegation of technical functions to nurses.
Aug 26, 2022
Aug 26, 2022
8 min
Following the August 24 Iowa Board of Pharmacy meeting, IPA staff and Sue Mears from the Board of Pharmacy discuss the rulemaking process and how a rule is adopted, as well as the Board’s newly adopted compounding rule. In addition, Becky Carlson speaks on the IMP3 Program and its importance in Iowa.
Jun 30, 2022
Jun 30, 2022
17 min
Following the June 28 Iowa Board of Pharmacy meeting, IPA staff and Sue Mears from the Board of Pharmacy discuss the Board’s updated security and controlled substance accountability rules, as well as changes to the Statewide Protocols for naloxone, immunization and tobacco cessation.
May 5, 2022
May 5, 2022
16 min
Following the May 3 Iowa Board of Pharmacy meeting, IPA staff and Sue Mears from the Board of Pharmacy discuss the FDA’s memorandum of understanding (MOU) for compounding pharmacies distributing medications interstate, the REMS comment period for opioid analgesics, new BOP security rules and more.
Mar 9, 2022
Mar 9, 2022
11 min
Following the March 1 Iowa Board of Pharmacy meeting, IPA’s Vice President of Government Affairs, Brett Barker, and Sue Mears from the Board of Pharmacy discuss the Board’s 2022 legislation regarding controlled substances and the authority of nurses practicing under a pharmacist’s order, as well as recent rulemaking and telepharmacy provisions from the Board.
Jan 14, 2022
Jan 14, 2022
23 min
Following the January 11 Iowa Board of Pharmacy meeting, IPA’s Government Relations team, Damian Thompson and Brett Barker, and Sue Mears from the Board of Pharmacy discuss federal comment periods for USP revisions, the DEA rulemaking regarding telepharmacy and transfer of electronic prescriptions for controlled substances, as well as recent rulemaking from the Board.
Nov 11, 2021
Nov 11, 2021
15 min
Following the November 10 Iowa Board of Pharmacy meeting, IPA’s Vice President of Public Affairs, Casey Ficek, and Sue Mears from the Board of Pharmacy discuss rule changes impacting telepharmacy, technicians, and potential legislation in the 2022 session.
Sep 2, 2021
Sep 2, 2021
14 min
Following the August 31 Board of Pharmacy meeting, IPA’s Vice President of Public Affairs, Casey Ficek, and Sue Mears from the Board of Pharmacy discuss the recently noticed collaborative practice rules and board approved test and treat protocols.